Depolarization block and phase II block at the neuromuscular junction

Area of Science:

• Neuromuscular Pharmacology
• Muscle Physiology

Background:

• Decamethonium and succinylcholine are neuromuscular blocking agents.
• Understanding their effects is crucial for clinical applications.
• Phase II block is a complex phenomenon requiring detailed study.

Purpose of the Study:

• To examine the effects of repeated decamethonium or succinylcholine doses on animal muscles.
• To compare different measures of electrical change at the end-plate region for assessing neuromuscular block.
• To quantitatively analyze the development of Phase II block.

Main Methods:

• Administered repeated doses of decamethonium or succinylcholine to cats, dogs, and rabbits.
• Measured electrical changes at the end-plate region.
• Correlated neuromuscular block degree with electrical measurements, including peak depolarization and peak spatial gradient.
• Utilized twitch height plotted against electrical change to monitor Phase II block.

Main Results:

• Peak spatial gradient of depolarization provided a more consistent measure of neuromuscular block than peak depolarization.
• A plot of twitch height versus electrical change served as a reference for quantitative Phase II block analysis.
• The extent and kinetics of Phase II block demonstrated considerable variation among different species and muscles within species.

Conclusions:

• The peak spatial gradient is a superior metric for quantifying neuromuscular block compared to peak depolarization.
• Twitch height-electrical change plots are valuable for studying Phase II block development.
• Species and muscle-specific differences significantly influence Phase II block characteristics.